topSkip to main content

Menu, Secondary

Menu Trigger

Menu

New York's Leading Public Research Universities on the Forefront of Education and Innovation

New York’s leading public research universities are on the forefront of education and scientific innovation.


Only sixty-five years young, Stony Brook University is recognized as one of the nation’s top research universities, serving as a powerful engine for economic development, technological innovation and clinical care. SBU is not only transforming lives by revolutionizing cancer prognosis and advancing life-saving technologies for cardiac patients but also by offering a world-class education to students from all socio-economic backgrounds, providing them unmatched social and economic mobility.

The University at Buffalo was recognized as a research powerhouse back in 1989, when it became the first public university in New York invited to join the AAU, and its impact has only grown over the years. From developing new ways to treat memory loss in Alzheimer’s to pioneering minimally invasive surgical techniques, UB is making discoveries that lead to longer, healthier lives.

Learn more about the amazing work happening every day at New York's flagship public research universities:

A University at Buffalo researcher is among the co-authors on a recent paper that reveals how loneliness during the COVID-19 pandemic has affected American women over the age of 70.
Researchers from the University at Buffalo are leading a project funded by the U.S. Department of Housing and Urban Development (HUD) that aims to shed light on the merits of mycelium-based soil remediation, while educating the public about the potential hazards of lead-contaminated soil.
Light therapy may accelerate the healing of skin damage from radiation therapy by up to 50%, according to a recent University at Buffalo-led study.
New discoveries from Stony Brook University experts lay the groundwork to better understand and treat Crohn’s disease, a type of Inflammatory Bowel Disease (IBD).
Research finds smaller dose of blood thinners is equally effective for blood clots and carries less bleeding risk